- Filed
- Jul 30, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2020 · Jul 28, 2021 | 6.03M sh |
| Shares Diluted | Q2 2020 · Mar 31, 2020 | 6.02M sh |
| Shares Diluted | Q2 2020 · Mar 31, 2020 | 6.02M sh |
| Shares Diluted restated | Q2 2020 · Mar 31, 2019 | 6.02M sh |
| Shares Diluted restated | Q2 2020 · Mar 31, 2019 | 6.02M sh |
| Operating Cash Flow | Q2 2020 · Mar 31, 2020 | −$123.1K |
| Operating Cash Flow | Q2 2020 · Mar 31, 2019 | −$47.93K |
| Cash And Equivalents | Q2 2020 · Mar 31, 2020 | $35.37K |
| Cash And Equivalents | Q2 2020 · Sep 30, 2019 | $393 |
| Cash And Equivalents | Q2 2020 · Mar 31, 2019 | $765 |
| Cash And Equivalents | Q2 2020 · Sep 30, 2018 | $3.13K |
| Stockholders Equity | Q2 2020 · Mar 31, 2020 | −$933.08K |
| Stockholders Equity | Q2 2020 · Dec 31, 2019 | −$777.44K |
| Stockholders Equity | Q2 2020 · Sep 30, 2019 | −$804.15K |
| Stockholders Equity | Q2 2020 · Mar 31, 2019 | −$619.03K |
| Stockholders Equity | Q2 2020 · Dec 31, 2018 | −$591.69K |
| Stockholders Equity | Q2 2020 · Sep 30, 2018 | −$613.84K |
| Current Liabilities | Q2 2020 · Mar 31, 2020 | $1.3M |
| Current Liabilities | Q2 2020 · Sep 30, 2019 | $1.2M |
| Total Liabilities | Q2 2020 · Mar 31, 2020 | $1.3M |
| Total Liabilities | Q2 2020 · Sep 30, 2019 | $1.2M |
| Current Assets | Q2 2020 · Mar 31, 2020 | $35.37K |
| Current Assets | Q2 2020 · Sep 30, 2019 | $393 |
| Total Assets | Q2 2020 · Mar 31, 2020 | $369.57K |
| Total Assets | Q2 2020 · Sep 30, 2019 | $393.59K |
| Eps Diluted | Q2 2020 · Mar 31, 2020 | −$0.03 |
| Eps Diluted | Q2 2020 · Mar 31, 2020 | −$0.03 |
| Eps Diluted | Q2 2020 · Mar 31, 2019 | $0.00 |
| Eps Diluted | Q2 2020 · Mar 31, 2019 | $0.00 |
| Eps Basic | Q2 2020 · Mar 31, 2020 | −$0.03 |
| Eps Basic | Q2 2020 · Mar 31, 2020 | −$0.03 |
| Eps Basic | Q2 2020 · Mar 31, 2019 | $0.00 |
| Eps Basic | Q2 2020 · Mar 31, 2019 | $0.00 |
| Sga Expense | Q2 2020 · Mar 31, 2020 | $108.74K |
| Sga Expense | Q2 2020 · Mar 31, 2020 | $147.36K |
| Sga Expense | Q2 2020 · Mar 31, 2019 | $44.1K |
| Sga Expense | Q2 2020 · Mar 31, 2019 | $99.7K |
| Net Income | Q2 2020 · Mar 31, 2020 | −$192.63K |
| Net Income | Q2 2020 · Mar 31, 2020 | −$165.91K |
| Net Income | Q2 2020 · Mar 31, 2019 | −$27.34K |
| Net Income | Q2 2020 · Mar 31, 2019 | −$5.18K |
| Operating Income | Q2 2020 · Mar 31, 2020 | −$108.42K |
| Operating Income | Q2 2020 · Mar 31, 2020 | −$146.93K |
| Operating Income | Q2 2020 · Mar 31, 2019 | −$26.66K |
| Operating Income | Q2 2020 · Mar 31, 2019 | −$52.15K |
| Gross Profit | Q2 2020 · Mar 31, 2020 | $319 |
| Gross Profit | Q2 2020 · Mar 31, 2020 | $428 |
| Gross Profit | Q2 2020 · Mar 31, 2019 | $17.44K |
| Gross Profit | Q2 2020 · Mar 31, 2019 | $47.55K |
| Cost Of Revenue | Q2 2020 · Mar 31, 2020 | $1.85K |
| Cost Of Revenue | Q2 2020 · Mar 31, 2020 | $7.19K |
| Cost Of Revenue | Q2 2020 · Mar 31, 2019 | $58.68K |
| Cost Of Revenue | Q2 2020 · Mar 31, 2019 | $106.7K |
| Revenue | Q2 2020 · Mar 31, 2020 | $2.17K |
| Revenue | Q2 2020 · Mar 31, 2020 | $7.62K |
| Revenue | Q2 2020 · Mar 31, 2019 | $76.12K |
| Revenue | Q2 2020 · Mar 31, 2019 | $154.24K |